MolNFT v1 · #151154 · protein
The structure of BOMAN26B, a GH26 beta-mannanase from bacteroides ovatus, complexed with G1M4
6HF4 · Glycosyl hydrolase family 26: “The structure of BOMAN26B, a GH26 beta-mannanase from bacteroides ovatus, complexed with G1M4”. X-ray diffraction, 4 ligands (BMA, GLA, CA), 1 pocket (best druggability 0.30). MolNFT v1 #151154 on…
- PDB
- 6HF4
- Type
- protein
- Length
- 325 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Glycosyl hydrolase family 26
- UniProt
- A7LW89
- Ligands
- BMA, GLA, CA, CL
- Pockets
- 1 · best druggability 0.30
Structure
x-ray diffraction · 1 distinct chain · 38% helix, 19% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Glycosyl hydrolase family 26 | protein | 325 | 38% helix, 19% strand | A7LW89 |
Ligands and binding sites
- BMA · beta-D-mannopyranose · sugar · 4 copies · chains A
- GLA · alpha-D-galactopyranose · sugar · chains A
- CA · Calcium ion · metal · chains A
- CL · Chloride ion · ion · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 80 | 0.30 | 0.72 | 18 | BMA |
Compared structures
- 6HF4 · The structure of BoMan26B, a GH26 beta-mannanase from Bacteroides ovatus, complexed with… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt A7LW89
- Elsewhere: RCSB PDB 6HF4 · PDBe 6HF4 · UniProt A7LW89
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.